Placebo-Controlled Trials and Active-Control Trials in the Evaluation of New Treatments. Part 2: Practical Issues and Specific Cases

  1. Susan S. Ellenberg, PhD; and
  2. Robert Temple, MD
  1. From the Center for Biologics Evaluation and Research and the Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Rockville, Maryland.
    1. Figure.
      View larger version:
      Figure. Considerations for use of placebo controls.
    « Previous | Next Article »Table of Contents

    This Article

    1. Ann Intern Med September 19, 2000 vol. 133 no. 6 464-470
    1. AbstractFREE
    2. » Figures
    3. Full Text
    4. Full Text (PDF)

    Rapid Responses

    1. Submit a response
    2. No responses published

    Current Issue

    1. November 3, 2009, 151 (9)
    1. Alert me to current issues